Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
That projection starts with first half 2025 semaglutide sales of about $16.4 billion (Ozempic about $9.4 billion, Wegovy roughly $5.4 billion, Rybelsus about $1.7 billion), annualizes that run rate to approximately $33 billion for full-year 2025, and incorporates Novos statement that recent U.S
"If this 'guinea pig' culture spreads, we risk a public health crisis of 'mystery' chronic conditions caused by these unregulated peptides that the traditional medical system isn't yet equipped to reverse." At the same time as millions of posts about peptides pop up across socials, a growing number of clinics are offering peptide therapy
Food & Drug Administration (FDA-a)
Users praise the structured coaching and daily lessons, though some note that the medication side of the program feels separate from the behavior coaching at times
